Palatin Technologies Stock Today
| PTN Stock | USD 0.91 0.07 7.14% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Palatin Technologies is selling at 0.91 as of the 2nd of March 2025; that is 7.14 percent decrease since the beginning of the trading day. The stock's open price was 0.98. Palatin Technologies has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 31st of January 2025 and ending today, the 2nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of October 1993 | Category Healthcare | Classification Health Care |
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company was founded in 1986 and is based in Cranbury, New Jersey. Palatin Technologies operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 26.01 M outstanding shares of which 1.28 M shares are at this time shorted by investors with about 0.88 days to cover. More on Palatin Technologies
Moving against Palatin Stock
| 0.36 | RNAC | Cartesian Therapeutics Earnings Call This Week | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Palatin Stock Highlights
| CEO | Carl Spana | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Proton Capital Corp., PRIMETRUST UNIT] | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Management, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPalatin Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Palatin Technologies' financial leverage. It provides some insight into what part of Palatin Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Palatin Technologies (PTN) is traded on NYSE MKT Exchange in USA. It is located in Cedar Brook Corporate Center, Cranbury, NJ, United States, 08512 and employs 30 people. Palatin Technologies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 23.74 M. Palatin Technologies runs under Biotechnology sector within Health Care industry. The entity has 26.01 M outstanding shares of which 1.28 M shares are at this time shorted by investors with about 0.88 days to cover.
Palatin Technologies has about 7.99 M in cash with (31.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Palatin Technologies Probability Of Bankruptcy
Ownership AllocationPalatin Technologies owns a total of 26.01 Million outstanding shares. Roughly 83.19 pct. of Palatin Technologies outstanding shares are held by general public with 2.63 % owned by insiders and only 14.18 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Palatin Ownership Details
Palatin Technologies Historical Income Statement
Palatin Stock Against Markets
Palatin Technologies Corporate Directors
| Joseph Hull | Independent Director | Profile | |
| Angela Rossetti | Independent Director | Profile | |
| Anthony Manning | Independent Director | Profile | |
| Alan Dunton | Independent Director | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palatin Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Palatin Stock, please use our How to Invest in Palatin Technologies guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palatin Technologies. If investors know Palatin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palatin Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share | Quarterly Revenue Growth (0.80) | Return On Assets | Return On Equity |
The market value of Palatin Technologies is measured differently than its book value, which is the value of Palatin that is recorded on the company's balance sheet. Investors also form their own opinion of Palatin Technologies' value that differs from its market value or its book value, called intrinsic value, which is Palatin Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palatin Technologies' market value can be influenced by many factors that don't directly affect Palatin Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palatin Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Palatin Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palatin Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.